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Background:  This  retrospective  study  compares  the  results  of  reconstruction  of isolated  chronic  anterior
cruciate  ligament  rupture  using  augmented  short  undersized  sized  hamstring  tendon  graft  with  ligament
advanced  artiﬁcial  reinforcement  system  (LARS)  versus  a four-strand  hamstring  tendon  graft  (4-SHG).  Our
hypothesis  was  that  postoperative  knee  stability  after  using  augmented  short  length  or  small  diameter
hamstring  tendon  graft  with  LARS  artiﬁcial  ligament  could  be signiﬁcant  and  satisfactory  more  than
4-strand  hamstring  tendon  graft  group.
Materials  and  methods:  Between  June  2007–July  2008,  72  patients  were  divided  into  a (LARS)  augmented
group  (n =  27) and  a (4-SHG)  group  (n  = 45).
Results:  Mean  FU  is  5 years.  KT-1000  examinations  showed  that  the LARS  group  had  signiﬁcantly  less
anterior  displacement  than  the  (4-SHG)  group  P = 0.013.  IKDC  score  demonstrated  statistically  signiﬁcant
differences  (P  =  0.05).
Conclusions:  Our  study  indicates  that  early  results  of augmenting:  short  length  or small  diameter  har-
vested hamstring  tendons  with  LARS  in ACL  reconstruction  provides  satisfactory,  comparable  results  and
displayed  higher  knee  stability  compared  to (4-SHG)  group.
Level  of evidence:  Level  III (case  control  study).
©  2015  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Once it has been established that an anterior cruciate ligament
ACL) deﬁcient knee is in need for reconstruction, a number of dif-
erent graft options are available. For the past two  decades, the
one-patellar tendon-bone (BPTB) autograft has been considered
he gold standard because of its osseous ﬁxation mode, but increas-
ngly the hamstring tendons have been used as an alternative graft
ue to the reduced donor site morbidity and signiﬁcantly improved
xation technique. It is currently the most common graft used
1]. Regardless the graft type, there can be a degree of morbidity
ollowing autograft harvest, which may  negatively affect recov-
ry after ACL reconstruction [1–3]. Therefore, the use of ligament
∗ Corresponding author. Al Razi Orthopaedic Hospital, Ministry of health Kuwait,
6  Gamal Abdel Naser street, PO Box 13043 Kuwait, Kuwait. Tel.: +96 599 522 942;
ax: +96 524 843 102.
E-mail address: fhf19633@yahoo.com (F. Hamido).
http://dx.doi.org/10.1016/j.otsr.2015.01.021
877-0568/© 2015 Elsevier Masson SAS. All rights reserved.advanced reinforcement system (LARS®) artiﬁcial ligament may
offer an alternative especially in case of short and undersized ham-
string tendons [2–4]. LARS® artiﬁcial ligament, (Surgical Implants
and Devices, Arc-sur-Tille, France) has recently reported to be a
suitable device due to its special design, and satisfactory clinical
results obtained following its use in ACL reconstruction [2,4–10].
Differing greatly from the older types of artiﬁcial ligaments (Dacron
Ligament Prosthesis, Versigraft carbon, Kennedy LAD, Xenograft,
Leeds-Keio), this generation of artiﬁcial ligaments shows encour-
aging clinical results as it is hydrophobic, chemically inert and
has high resistance to fatigue especially ﬂexion-torsion stresses
and elongation; its porosity is favourable for ﬁbroblastic ingrowth
[2,3,8,10].
The use of LARS® artiﬁcial ligament has been gradually increased
and become more popular [2,8–15].Certain patients with short (less than 15 cm length) and
small diameter hamstring tendon grafts increase the needs for
augmenting such tendons [3]. Pichler et al. [16] explored the cor-
relation between the length, cross-sectional area of the harvested
5 ology: Surgery & Research 101 (2015) 535–538
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endons and the body height and length of the femur. He stated that
urgeons should be aware of the possibility of encountering insuf-
cient length of tendon when undertaking reconstructive surgery
ecause of anatomical variations between patients. We  used LARS®
rtiﬁcial ligament to reinforce the short length (< 15 cm)  and the
mall diameter harvested four-strand hamstring tendon graft (less
han 5.5–6 mm)  in diameter which is not uncommon in our popu-
ation [3,16], aiming for having the beneﬁts of getting higher knee
tability due to early revascularization and cell proliferation and
hus to allow early return to unrestricted sport activity and ensure
ong term survival of the graft [17–21].
To our knowledge, there are no studies comparing (4-strand
amstring tendon graft) autografts and the augmented LARS® arti-
cial ligament in ACL reconstruction.
The aim of this study was to compare the outcome of ACL
econstruction using augmented hamstring tendon graft with LARS
rtiﬁcial ligament versus a four-strand hamstring tendon graft (4-
HG) to assess the effectiveness of the two grafts regarding to knee
tability.
Our hypothesis was that postoperative knee stability was better
n LARS® augmented group.
. Material and methods
From June 2007 to July 2008, 104 patients with isolated tear
f anterior cruciate ligament were reconstructed using either
4-SHG) or (LARS) augmented graft. The diagnosis of chronic
igament tear was identiﬁed by positive lachman, s-test, ante-
ior drawer test pivot shift test and magnetic resonance imaging
MRI). Exclusion criteria were patients less than 6 months from
njury, combined ligament injury, radiological visible degenerative
hanges, contralateral knee ligament injury and follow-up period
ess than ﬁve years. Seventy-two patients fulﬁlled these criteria and
ere included. Twenty-seven patients were found having intra-
peratively either short hamstring tendons (< 15 cm length) or
mall diameter harvested four-strand graft (less than 6 mm diam-
ter); they where reconstructed with augmentation using LARS®
rtiﬁcial ligament. Forty-ﬁve patients were reconstructed with a (4-
HG). Each patient was informed in details regarding to the nature
f his injury, possibility of augmentation of the harvested graft with
ARS® artiﬁcial ligament and the surgical procedure. The patients
ave the informed consent prior being included into the study;
he study was authorized by the local ethical committee and was
erformed in accordance with the Ethical standards of the 1964
eclaration of Helsinki as revised in 2000.
The two groups were comparable in terms of gender, age, cause
f injury, time from injury to surgery and preoperative Lysholm and
egner scores. All procedures were done by one senior surgeon (FH)
Table 1).
.1. Surgical techniqueReconstruction was done under arthroscopic control. The ACL
tump with synovial covering was preserved as much as possible.
he semitendinosus and gracilis tendon were harvested through
able 1
emographics in LARS® and 4-SHG groups.
Group Male/female Mean age at surgery Cause of injury 
Trafﬁc Fall 
LARS®
(n = 27)
27/0 24 (21–35) 6 18 
4-SHG
(n  = 45)
44/1 20 (18–31) 13 25 Fig. 1. A. Augmented graft preparation. B. Augmented graft (ﬁnal appearance).
2–3 cm incision medial to the tibial tuberosity. In the (4-SHG)
group, the tendons were prepared to form a quadruple strand graft.
In case of short length or small diameter tendons, LARS Artiﬁcial lig-
ament (3.5 mm)  diameter was used to reinforce the tendons with
web stitch sutures using coated vicryl rapide 2-0 (Fig. 1A and B). The
relative size of the 4-strand augmented LARS graft was (8–9 mm)  in
diameter as the same as (4-SHG). All the patients underwent arthro-
scopic single bundle ACL reconstruction (Rigidﬁx technique Mitek
Johnson & Johnson), the tibial tunnel was  drilled using the aiming
guides. For the femoral tunnel, an appropriate femoral offset guide
placed the positions of 2 O’clock and 10 O’clock for left and right
knees, respectively. Transtibial drilling of the femur at the correct
position to depth of 30 mm.  Using the (Mitek) transtibial cross-pin
guide, two cross-pin locking holes were fashioned from the lateral
aspect of the femur to ﬁx femoral end of the graft with two  RigidFix
cross-pins (Mitek) once the graft had been drawn into the femoral
tunnel to a depth of 30 mm.  After tensioning, the tibial end of the
graft was  ﬁxed with a bioabsorbable screw (Fig. 2).
Mean time to urgery
(months)
Lysholm Score
(mean + SD)
Tegner Score
(mean + SD)
Fall Preop Preop
3 7 (6–31) 43.6 ± 3.6
P = 0.239
3.6 ± 0.7
P = 0.368
7 8 (6–29) 42.3 ± 5.2 3.3 + 0.3
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Table 2
Postoperative KT-1000 examination results at 5 years follow-up.
Group Side-to-side difference (No. of pts)
< 3 mm 3–5 mm 6–10 mm > 10 mm
Average
(mean ± SD)
LARS® (n = 27) 24 3 0 0 1.1 ± 0.3 mm
T
IFig. 2. Augmented ACL single bundle graft.
Rehabilitation protocol was the same in the two  groups. Quadri-
eps isometric closed kinetic-chain exercises and straight leg raises
ere initiated as early as possible. Knee ﬂexion began from 45◦
nd increased gradually to complete ﬂexion and extension within
he ﬁrst week. Crutches were used for 3 weeks. Static stepping
or balance was allowed for the ﬁrst few weeks followed by full
eight bearing after 4 weeks postoperative. Cycling was  permit-
ed 4–5 weeks postoperatively. Patients usually returned to normal
aily activity and allowed to participate in non-competitive sports,
hich did not include pivoting sports or recreational skiing in four
onths, and returned to sport activity after six months.
.2. Evaluation
The minimum follow-up was 58 months and the mean follow-
p was 59 months (range 58–62 months). All the examinations and
esults were evaluated at follow-up by a single orthopaedic sur-
eon (TA) who was not involved in the patient care. All patients
valuations were performed pre- and postoperatively by clini-
al examination, a patient satisfaction questionnaire [Knee Injury
nd Osteoarthritis Outcome Score (KOOS)] [22], measurement
f joint laxity with the KT1000 arthrometer (Med meteric, San
iego, California), the International Knee Documentation Commit-
ee objective Scale (IKDC) [22,23], Lysholm, Tegner activity scores
nd radiological evaluation [24].
.3. Statistical analysis
The data at the latest follow-up were statistically analysed with
PSS 11.0 software (Nie, Bent and Hull) – Chicago. The results were
ompared between the two groups using (t-test) for continuous
easurements, Chi2 test for nominal data and Wilcoxon signed
ank test for ordered categorical variables, respectively. P value
f < 0.05 was considered statistically signiﬁcant.. Results
Patients in both groups had no immediate postoperative com-
lications that required revision or readmission. One patient in
able 3
KDC Score.
LARS® group (n = 27)
Final IKDC results Preoperative 2nd year postop 5th year
Normal A 0 21 20 
Nearly  normal B 0 5 6 
Abnormal C 10 1 1 
Severely abnormal D 17 0 0
P = 0.054-SHG (n = 45) 32 9 4 0 2.5 ± 0.5 mm
P  value P = 0.013 P = 0.027
4-SHG group felt paraesthesia on the medial side of the knee
recovered around 9 months postoperatively, one patient in (4-SHG)
group developed type 2 arthroﬁbrosis that “required” arthro-
scopic lysis and patient achieved full knee ﬂexion with loss of last
5–10◦ of extension. Mean side-to-side difference with KT-1000 was
1.1 ± 0.3 mm and 2.5 ± 0.5 mm in LARS® group and (4-SHG) group,
respectively (P = 0.013). The side-to-side difference was less than
3 mm  in 24 patients (92%) in the LARS® group and 32 patients (71%)
in the (4-SHG) group.
The stability results showed that the LARS® group had signiﬁ-
cantly less anterior displacement than the (4-SHG) group (Table 2).
The mean Lyshlom scores were 95.3 ± 7.3 and 90.1 ± 6.9
(P = 0.239), and the mean Tegner scores were 7.4 ± 1.8 and 6.7 ± 1.5
(P = 0.368) in LARS group and 4-SHG group, respectively.
In terms of IKDC, 26 patients (96.3%) in the LARS® group and
39 patients (85.5%) in the 4-SHG group were graded as normal or
nearly normal at 2 years follow-up (P = 0.215). Twenty-six patients
(96.3%) in the LARS® group and 32 (71.1%) patients in the 4-SHG
group were graded as normal or nearly normal at 5 ± years follow-
up (P = 0.05) (Table 3).
KOOS pain score averaged 81.2 and 84.6, KOOS symptoms score
(stiffness, swelling, catching) averaged 78.2 and 86.3 while KOOS
activities of daily living averaged 92 and 94.2 in the 4-SHG group
and LARS group respectively, but there were no signiﬁcant dif-
ferences (P = 0.308). Radiological evaluation during and at 5-year
follow-up showed no marked osteoarthritic changes.
4. Discussion
The purpose of this study was to compare the results of ACL
reconstruction using either LARS® augmented graft or 4-SHG. The
most important ﬁnding of the present study is that using LARS®
augmented graft in patients with short and undersized harvested
hamstring tendons gives superior results than 4-SHG in terms of
laxity. In terms of IKDC, LARS® augmented group has signiﬁcantly
better results than 4-SHG group at 5-year follow-up.
Graft tissue revascularization starts within the ﬁrst 2 to 4 weeks
after surgery, highest vascular density in the graft tissue is found
at 6 weeks and reaches an end point compared with the vascular
status of the native ACL after approximately one year [18–21,25].
Autogenous grafts are thought to be weaker than artiﬁcial sub-
stances at implantation and undergo a period of morphological
change with further weakening [24].
Artiﬁcial reconstruction of the ACL with the use of various mate-
rials was recommended in early 1980s. The following old types of
artiﬁcial ligaments were analyzed biochemically and histologically:
4-SHG group (n = 45)
 postop Preoperative 2nd year postop 5th year postop
0 32 26
0 7 6
17 6 11
28 0 2
P = 0.215
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ORE- TEX (W.L. Gore and Co., Flagstaff, Ariz.), Dacron Ligament
rosthesis (Stryker), Versigraft carbon, Kennedy LAD (3 M com-
any USA), Xenograft, Leeds-Keio by (Xiros, Leeds (UK)). All these
igaments proved to induce synovits [11–15].
LARS® artiﬁcial ligament is made of industrial strength polyester
bers (polyethylene terephatalate). Resistance to traction varies
ith the number of the longitudinal ﬁbers. These resistances are
pproximately 1500 N for 30 ﬁbers up to 4700 N for 100 ﬁbers.
his patented structure allows a high resistance to fatigue espe-
ially ﬂexion-torsion stresses and elongation, and its porosity is
avourable for ﬁbroblastic ingrowth. The LARS(R) ligament is min-
mally elastic. Under persistent traction of 1700 N and relaxation
ver 24 h, the length increased less than 1.5% [10,11,14,15,26].
Trieb et al. [17] stated that biopsies taken from LARS(R) 6 months
fter implantation show a complete cellular and connective tissue
ngrowth. The ﬁbroblasts and osteoblast-like cells encapsulated the
igament ﬁbers by building a cellular net around them; this mech-
nism might explain the strength and the inert behavior of the
igament without synovitis shown in clinical studies.
Nau et al. [10] conclude that reconstruction of the ACL using
he LARS(R) ligament in chronic ACL-deﬁcient patients gives high
atient satisfaction during the ﬁrst 24 months. The results sug-
est that full return to activity may  be achieved earlier and
ay  offer the possibility of a shorter period of rehabilitation
specially in the ﬁeld of sports medicine. The encouraging early
esults using the LARS(R) ligament are to be maintained, as it
ould reduce the current prejudice against the use of artiﬁcial
igaments.
Bin Li et al. [5] demonstrated in their comparative study that
he use of LARS® artiﬁcial ligament for posterior cruciate ligament
PCL) reconstruction is clinically more useful than using a 4-SHG
egarding restoration of both the knee stability and the knee func-
ion.
Beauﬁls et al. [13] analyzed the results of PCL reconstruction
ith adjunction of a LARS® ligament for major recent isolated or
ombined laxity of the posterior cruciate ligament. They conclude
hat synthetic ligament acts as a tutor for healing of the torn liga-
ent.
There is no available studies in the current literature evaluating
he strength of LARS® augmented hamstring tendon graft during
nd after the course of ligamentization and comparing it with 4-
HG in terms of restoration of the knee function and stability. In this
tudy, better knee stability outcome is obtained in the LARS® aug-
ented group despite the worst scenario (thin or short hamstrings
rafts). The strength of 4-SHG decreases after reconstruction by
longation as it undergoes a period of morphological changes with
urther weakening.
Recently, Ventura et al. [27] evaluated prospectively the out-
ome of ACL reconstruction using polyethylene terephthalate (PET)
rtiﬁcial ligaments in sportsmen, with a follow-up extending
o 19 years. They suggest that artiﬁcial ligaments could con-
ribute to the establishment of the degenerative osteoarthritic
rocess.
In our study, we did not ﬁnd any sign of marked osteoarthritis
n LARS® group nor clinical evident synovitis.
This study has some limitations. The total number of patients
s not large and the mean follow-up is not too long. The design is
on-randomized and retrospective.
Our study indicates that reinforcing short length or small diame-
er harvested hamstring tendons with LARS® in ACL reconstruction
ives higher knee stability and satisfactory comparable results
ompared to (4-SHG) group.
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